SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 61 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $26,222,000 | -63.7% | 14,365,000 | -51.3% | 0.17% | -64.1% |
Q3 2014 | $72,236,000 | -30.5% | 29,516,000 | -44.3% | 0.48% | -26.9% |
Q2 2014 | $103,949,000 | -9.9% | 52,965,000 | -22.5% | 0.66% | -10.6% |
Q1 2014 | $115,311,000 | +9.1% | 68,318,000 | -3.0% | 0.74% | +9.7% |
Q4 2013 | $105,713,000 | +4.6% | 70,422,000 | -14.0% | 0.67% | +6.0% |
Q3 2013 | $101,055,000 | +1.8% | 81,844,000 | -1.4% | 0.63% | -2.3% |
Q2 2013 | $99,291,000 | – | 83,000,000 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $5,117,000 | 4.90% |
SILVERBACK ASSET MANAGEMENT LLC | 18,209,000 | $33,322,000 | 4.30% |
RAVEN ROCK CAPITAL MANAGEMENT, LLC | 1,000,000 | $1,990,000 | 2.80% |
Verition Fund Management LLC | 5,504,000 | $10,062,000 | 2.26% |
CAMDEN ASSET MANAGEMENT L P /CA | 26,798,000 | $48,856,000 | 1.81% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $15,679,000 | 1.60% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 3,000,000 | $5,490,000 | 1.46% |
BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $8,782,000 | 1.40% |
Wellesley Asset Management | 12,564 | $23,006,000 | 1.35% |
WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $56,979,000 | 1.11% |